We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New H&E Tissue Staining Solution Sets New Standard in Histopathology

By LabMedica International staff writers
Posted on 07 Dec 2015
Print article
A new hematoxylin and eosin (H&E) staining system provides exceptionally high tissue staining quality and efficiency that enhances patient care as well as lab technician safety.

The new “VENTANA HE 600” staining system from Roche (Basel, Switzerland) delivers fresh reagents on each individual slide without relying on user-supplied alcohol and deionized (DI) water, resulting in improved consistency and quality. This individual slide staining technology mitigates the risk of specimen cross-contamination that can occur with other technologies, helping to reduce patient misdiagnosis.

Elimination of xylene and alcohol and utilization of ready-to-use reagents reduce technician exposure to harmful chemicals. Workflow is improved by eliminating the need to manually mix reagents and track product expiration dates. The system offers over 400 individual staining protocols and is highly customizable, allowing for laboratory and pathologist preferences and tissue variables.

In a recent global test, over 4,000 slides from laboratories in 12 countries were stained on VENTANA HE 600 and reviewed by 67 pathologists with excellent results. Evaluation of the criteria, including nuclear detail and stain quality and intensity, resulted in a score of 3.7 on a scale of 4.0.

Robert C. Babkowski, MD, the lead pathologist on a recent 4-week beta-test conducted at Stamford Hospital where he reviewed over 1,000 slides, said, “When we compared our current system, the VENTANA HE 600 system is easier to use, the slides are exquisite, and the consistency is solid. The new system provides beautifully stained slides every time and has allowed me, as a working pathologist, to be even more efficient. Because the instrument is so easy to operate, my histo-technologists are now able to focus on other key histology functions.” Stamford Hospital is one of 4 beta-test sites.

“Approximately 80% of a pathologist's diagnostic report comes from the H&E stain. The VENTANA HE 600 system will help change the standard of care for laboratories, pathologists and, most importantly, cancer patients, who rely heavily on the H&E test,” said Roland Diggelmann, COO, Roche Diagnostics Division, “The system reflects Roche’s commitment to delivering innovation that meets the labs’ needs of today and tomorrow through meaningful advancements in staining quality, patient and laboratory safety, and workflow.”

Related Links:

Roche


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.